Ipca Laboratories informs about media release

06 Aug 2024 Evaluate

Ipca Laboratories has informed that it enclosed the media release issued by the Company with respect to launch of patented novel drug branded as ‘Diulcus’ in the Indian market for treatment of Diabetic Foot Ulcer (DFU). Currently there is a global unmet medical need for treatment of DFU which is the most prevalent complication caused by chronic diabetes.

The above information is a part of company’s filings submitted to BSE.


Ipca Laboratories Share Price

1441.95 -11.80 (-0.81%)
20-Sep-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.60
Dr. Reddys Lab 6552.50
Cipla 1639.50
Lupin 2152.15
Zydus Lifesciences 1055.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.